We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.64%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+354.85%
AUM
$551M
AUM Growth
-$16.6M
(-2.9%)
Cap. Flow
-$1.49M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
21.07%
Holding
271
New
8
Increased
79
Reduced
44
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$1M |
| 2 |
Unisys
UIS
|
+$920K |
| 3 |
Global Ship Lease
GSL
|
+$917K |
| 4 |
Johnson Outdoors
JOUT
|
+$916K |
| 5 |
Allient
ALNT
|
+$893K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LDL
Lydall, Inc.
LDL
|
+$3.04M |
| 2 |
SYKE
SYKES Enterprises Inc
SYKE
|
+$1.28M |
| 3 |
BioLife Solutions
BLFS
|
+$1.03M |
| 4 |
GPX
GP Strategies Corp.
GPX
|
+$821K |
| 5 |
Apple
AAPL
|
+$482K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.19% |
| 2 | Consumer Discretionary | 17.96% |
| 3 | Technology | 14.41% |
| 4 | Financials | 11.77% |
| 5 | Healthcare | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-226
| Closed | -$46K |
|
252
Viatris
VTRS
$19B
| – | – |
-433
| Closed | -$6K |
|
253
Wabtec
WAB
$49.9B
| – | – |
-20
| Closed | -$2K |
|
254
Wells Fargo
WFC
$265B
| – | – |
-600
| Closed | -$27K |
|
255
Walmart Inc
WMT
$892B
| – | – |
-300
| Closed | -$14K |
|
256
State Street Energy Select Sector SPDR ETF
XLE
$38.1B
| – | – |
-762
| Closed | -$21K |
|
257
Zimmer Biomet
ZBH
$18.8B
| – | – |
-317
| Closed | -$50K |
|
258
Zebra Technologies
ZBRA
$17.2B
| – | – |
-120
| Closed | -$64K |
|
|
XYZ
259
Block Inc
XYZ
$47B
| – | – |
-200
| Closed | -$49K |
|
|
XM
260
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| – | – |
-500
| Closed | -$19K |
|
|
CVET
261
DELISTED
Covetrus, Inc. Common Stock
CVET
| – | – |
-476
| Closed | -$13K |
|
|
WBT
262
DELISTED
Welbilt, Inc.
WBT
| – | – |
-800
| Closed | -$19K |
|
|
CLDR
263
DELISTED
Cloudera, Inc.
CLDR
| – | – |
-3,000
| Closed | -$48K |
|
|
LDL
264
DELISTED
Lydall, Inc.
LDL
| – | – |
-50,243
| Closed | -$3.04M |
|
|
SYKE
265
DELISTED
SYKES Enterprises Inc
SYKE
| – | – |
-23,805
| Closed | -$1.28M |
|
Similar funds
CM
CFFNO
TBA
JSC
MSIIA
WHCM
OPFM
RC
Isthmus Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Isthmus Partners held 271 positions worth $551M, down 2.9% from $568M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Isthmus Partners's Q3 2021 filing shows 8 new, 79 increased, 44 reduced and 118 closed positions. Its largest new stake was SPDR Gold Trust: 6,000 shares worth $985K. The largest sale was Lydall, Inc., an estimated $3.04M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Isthmus Partners's largest Q3 2021 buy was SPDR Gold Trust: 6,000 shares worth $985K.
- Isthmus Partners added most to Johnson Outdoors in Q3 2021, an estimated $916K increase.
- Isthmus Partners's biggest Q3 2021 reduction was BioLife Solutions, cutting an estimated $1.03M.
- Isthmus Partners fully exited Lydall, Inc. in Q3 2021, selling an estimated $3.04M.
- Isthmus Partners's ten largest holdings make up 21% of its $551M portfolio in Q3 2021.
- Isthmus Partners opened 8 new positions and closed 118 in Q3 2021.
- Isthmus Partners's portfolio value fell 2.9% quarter-over-quarter to $551M.
Based on Isthmus Partners's 13F filing for Q3 2021, filed 10 Nov 2021.